Journal article · 2001 · Open access

Analyzing the National Cholesterol Education Program Adult Treatment Panel III Report: Is New Better?

Jan Basile

Journal of Clinical Hypertension, 3(5), 292–295 · Published 1 September 2001 · DOI 10.1111/j.1524-6175.2001.01052.x

Read the free full textView at the publisherCite this paper

In brief

“Analyzing the National Cholesterol Education Program Adult Treatment Panel III Report: Is New Better?” is a 2001 journal article by Jan Basile, published in Journal of Clinical Hypertension. OpenAlex counts 2 citations as of 15 November 2026, which puts it in the top 9% of works published in 2001 by citations. It is open access: the full text is free to read at PubMed Central.

Citations
2
Most cited in
2026 (1)
Field-weighted impact
0.23
References
6
Authors
1

Abstract

The recently released Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III [ATP III]) summarizes an evidence-based report that expands on the clinical and scientific rationale for intensive cholesterol-lowering therapy in clinical practice. Representing 20 months of work by an expert panel comprising 27 leading clinicians and researchers, the executive summary1 is based on a lengthy (more than 200 pages), comprehensive report, available on the internet (http://www.nhlbi.nih.gov/guidelines/cholesterol/index.htm). Building on the core of the previous reports, released in 1986 (ATP I) and 1993 (ATP II), this new report constitutes a more rational, evidence-based approach to the prevention and treatment of high blood cholesterol in adults. How is this document different from its predecessors? Does it extend our ability to treat as well as prevent coronary heart disease (CHD)? How is this document applicable to the treatment of hypertension? These and other aspects of the document will be discussed in this editorial. The new summary expands on the core content of the previous two reports and proposes to update the clinical management of high blood cholesterol. In ATP I, a strategy for the primary prevention of CHD in patients without disease but with two or more risk factors and an elevated level of low-density lipoprotein cholesterol (LDL-C) was established. ATP II, expanding on the previous document, recommended that the goal for LDL-C in those with established CHD be ≤100 mg/dL. Utilizing a modified form of the Framingham risk score, the major emphasis of ATP III is on predicting the 10-year absolute risk for developing CHD in a patient with two or more risk factors (one of which may be hypertension). In all adults 20 years of age or older, a fasting lipoprotein profile (total Cholesterol, LDL-C, high-density lipoprotein [HDL-C], and triglyceride [TG]) should be obtained once every 5 years. If a nonfasting specimen is obtained, only total cholesterol and HDL-C will be usable. The major new focus is on the primary prevention of CHD, as many individuals are at high risk for CHD and will benefit from more intensive LDL-C lowering. The concept of “coronary risk equivalents” is developed. Those with peripheral arterial disease, abdominal aortic aneurysm, symptomatic carotid artery disease (transient ischemic attacks or stroke), and diabetes will be treated similarly to those with established CHD, as their risk of having a major coronary event is the same, i.e., >20% over the next 10 years. The optimal LDL-C goal of…

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Basile, J. (2001). Analyzing the National Cholesterol Education Program Adult Treatment Panel III Report: Is New Better? Journal of Clinical Hypertension, 3(5), 292–295. https://doi.org/10.1111/j.1524-6175.2001.01052.x

MLA 9

Basile, Jan. “Analyzing the National Cholesterol Education Program Adult Treatment Panel III Report: Is New Better?” Journal of Clinical Hypertension, vol. 3, no. 5, 2001, pp. 292–295. https://doi.org/10.1111/j.1524-6175.2001.01052.x.

Chicago

Basile, Jan. 2001. “Analyzing the National Cholesterol Education Program Adult Treatment Panel III Report: Is New Better?” Journal of Clinical Hypertension 3 (5): 292–295. https://doi.org/10.1111/j.1524-6175.2001.01052.x.

Harvard

Basile, J. (2001) ‘Analyzing the National Cholesterol Education Program Adult Treatment Panel III Report: Is New Better?’, Journal of Clinical Hypertension, 3(5), pp. 292–295. doi:10.1111/j.1524-6175.2001.01052.x.

IEEE

J. Basile, “Analyzing the National Cholesterol Education Program Adult Treatment Panel III Report: Is New Better?,” Journal of Clinical Hypertension, vol. 3, no. 5, pp. 292–295, 2001, doi: 10.1111/j.1524-6175.2001.01052.x.

BibTeX

@article{basile2001analyzing,
  title     = {{Analyzing the National Cholesterol Education Program Adult Treatment Panel III Report: Is New Better?}},
  author    = {Basile, Jan},
  journal   = {Journal of Clinical Hypertension},
  year      = {2001},
  volume    = {3},
  number    = {5},
  pages     = {292--295},
  doi       = {10.1111/j.1524-6175.2001.01052.x},
  url       = {https://doi.org/10.1111/j.1524-6175.2001.01052.x}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health

  • NCEP ATP III criteria
  • high blood cholesterol
  • LDL cholesterol lowering
  • coronary heart disease prevention
  • Framingham risk score
  • dyslipidemia
  • hypertension
  • lipid screening

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Basile, J. (2001). Analyzing the National Cholesterol Education Program Adult Treatment Panel III Report: Is New Better? Journal of Clinical Hypertension, 3(5), 292–295. https://doi.org/10.1111/j.1524-6175.2001.01052.x

How many times has this paper been cited?

2 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at PubMed Central.

Who wrote this paper?

Jan Basile.

What is the DOI of this paper?

10.1111/j.1524-6175.2001.01052.x. The permanent link is https://doi.org/10.1111/j.1524-6175.2001.01052.x.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.